Top Health Tech Companies in San Diego, CA (420)
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Schrödinger, Inc.'s Top Stability & Growth Strengths
Strong Revenue Growth: Recent results indicate total revenue increased year over year in 2025 and continued to rise in the latest reported quarter. Guidance and quarterly updates point to ongoing top-line expansion even as mix shifts occur.
Resilient & Sustainable Growth: Underlying annual contract value expanded and accelerated in 2026, with management indicating continued growth despite the transition to hosted licensing. This suggests the core subscription base is strengthening even when reported revenue timing varies.
Diversified Revenue Streams: Growth is visible in both the software business and the milestone-driven drug discovery segment. The latter stepped up meaningfully in recent periods, complementing steady software momentum.
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.
Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.
Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.
ZS is a management consulting and technology firm that partners with companies to improve life and how we live it. We transform ideas into impact by bringing together data, science, technology and human ingenuity to deliver better outcomes for all. Founded in 1983, ZS has more than 15,000+ employees in over 40 offices worldwide.
ZS's Top Stability & Growth Strengths
Strong Hiring & Retention: Hiring and headcount are expanding, with disclosures of 15,000+ global employees, thousands of new hires, and third‑party estimates indicating continued workforce growth. Available evidence also points to active internal mobility and a recent increase in active job postings.
Market Expansion: Geographic and client footprints are broadening, with 40+ offices and 1,700+ customers across 170+ countries alongside concrete investments in new and expanded locations such as Hyderabad and Kingston. These moves indicate scaling delivery capacity in major capability centers and new regions.
Innovation-Driven Growth: The offering mix is shifting toward AI, data, technology, and platforms, including proprietary solutions and product capabilities. Strategic moves such as Salesforce-focused acquisitions and collaborations, plus a Tulip solution partnership, extend capabilities beyond traditional consulting.
Our purpose ensures that patients remain at the center of all we do. We live our purpose by sourcing the best science in the world; partnering with others in the healthcare system to improve access to our medicines; using digital technologies to enhance our drug discovery and development, as well as patient outcomes; and leading the conversation to advocate for...
Pfizer's Top Stability & Growth Strengths
Product Line Growth: Growth across non‑COVID medicines such as Eliquis, Padcev, the Vyndaqel family, Lorbrena, Nurtec/Vydura and oncology biosimilars has been robust. Launched and acquired products are showing sustained double‑digit operational gains, adding meaningful momentum.
Resilient & Sustainable Growth: Excluding COVID products, the underlying portfolio delivered mid‑single‑digit operational growth in 2025 and continued at a similar pace in early 2026, more than offsetting part of the COVID‑related decline. Reported revenue also returned to modest year‑over‑year growth in the first half of 2026, indicating stabilization.
Future-Ready Strategy: Management raised the midpoint of 2026 revenue guidance and continues to invest heavily in a broad late‑stage pipeline. This posture signals confidence that newer launches and acquired assets can drive the next leg of growth.
TrueMed is a payments tool (think PayPal for HSA/FSA) that allows health + wellness brands to accept HSA/FSA funds. We are partnering with leading health and wellness brands such as CrossFit, Magic Mind, and DB Method to drive increased AOV (30%+ for many leading merchants), retention (40% increase in month 2 retention) and LTV. Our implementations are simple (official Shopify payments...
HumanGood is a non-profit organization that operates life plan communities and affordable housing for older adults, dedicated to changing how aging is experienced and perceived.
ATEC Spine is a medical device company dedicated to revolutionizing the approach to spine surgery through innovation. ATEC’s Organic Innovation Machine™ is the greatest concentration of spine know-how in the industry and committed to the creation of clinical distinction. Leveraging 100% spine focus and expertise, we seek to improve spine surgery by rethinking, redesigning and seamlessly integrating the technologies required...
Rogers Behavioral Health is a leading, national not-for-profit provider of highly specialized psychiatric care and addiction treatment. The organization offers evidence-based treatment for children, adolescents, and adults struggling with OCD, anxiety, depression, mood disorders, eating disorders, trauma, and PTSD. With a growing network of communities across the U.S. and over a century of experience, Rogers is dedicated to improving clinical...
Evolve Treatment Centers provides comprehensive behavioral health care specializing in adolescent mental health and substance abuse treatment for teens aged 12-17. Their mission is to empower youth struggling with mental health and substance use issues to heal and recover through individualized, evidence-based therapies—including Dialectical Behavior Therapy (DBT)—offered in residential and outpatient settings throughout California.
Wonderist Agency is a full-service marketing agency for dental practices to help them grow their new patient base through a personalized, results-focused marketing plan. We pride ourselves on our personalized approach to each of our client's needs and are committed to working as part of your existing team. Our Services Account Management: Are you tired of managing lots of marketing partners and...
Cortica is a rapidly growing healthcare company pioneering a unique and effective approach to treating neurodevelopmental conditions including autism spectrum disorder, speech and language delays, sensory processing disorder and other conditions that impact brain development. Harnessing insights and technologies from emerging neuroscience, Cortica brings together clinical specialists from a range of disciplines to design and deliver comprehensive care to children...
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Established in 2009, Mission Healthcare is a leader in home-based healthcare. With a West Coast footprint of 28 locations across seven states, the Medicare-certified provider delivers personalized skilled home health, hospice, and transitional care services to more than 30,000 patients. Mission aims to provide high-quality, cost-effective, home-based healthcare with a dedicated staff of more than 1,800 employees. As a preferred...
Eli Lilly and Company engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment. For more than a century, we have stayed true to a core set of values – excellence, integrity, and respect for people – that guide us in all we do: discovering medicines that meet real needs, improving the understanding and management of...
Eli Lilly and Company's Top Stability & Growth Strengths
Strong Market Position & Advantage: By market value and category leadership in incretins, Lilly sits at or near the top of global pharma. Mounjaro/Zepbound are redefining obesity/diabetes, with Mounjaro becoming the world’s best‑selling prescription drug in early 2026.
Strong Revenue Growth: Results show outsized, volume-led acceleration, with Q1 2026 revenue reaching $19.8B. Management also raised 2026 sales guidance to about $82–$85B after very strong 2025 growth.
Innovation-Driven Growth: Recent approvals and pipeline progress beyond metabolic disease add new growth pillars. The FDA approval of Kisunla (donanemab) in 2024 and advancement of oral GLP‑1 programs broaden the portfolio.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for...
Planned Parenthood Great Rivers is a patient-focused health care organization that provides, protects, and supports sexual and reproductive health services, access, and rights. It serves as a leading provider, educator, and protector of reproductive health care in the St. Louis region, Missouri Ozarks, and beyond, offering high-quality, convenient health care for all genders with or without insurance.
Third Space Therapy operates a teletherapy platform providing rapid access to mental health services for individuals covered by Medicaid and commercial insurance, offering remote sessions and provider matching.
Natus Medical Incorporated (Natus) offers medical equipment, software, supplies and services for the diagnosis, monitoring, and treatment of impairments and disorders effecting the brain, neural pathways, and eight sensory nervous systems. Our comprehensive product portfolio represents a heritage of innovation and leadership. Natus brands have been setting the standard for patient care for over eighty (80) years. Our products are trusted...
Total Vision LLC is a California-based group of optometry practices focused on delivering high-quality, world-class eye care. It partners with independent eye-care professionals and operates practices across California, providing comprehensive vision services, including eye examinations, eyewear, contact lenses, ocular-disease management, and pre- and post-operative care. Its mission is to improve patients’ vision and lives through an extraordinary standard of care.
Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted...
Foundation Medicine's Top Stability & Growth Strengths
Strong Market Position & Advantage: Industry analyses consistently place the company among the top global players in oncology companion diagnostics and CGP, shaping market trends and standards. First‑mover FDA approvals and broad Medicare coverage, plus the largest reported CDx indication footprint, reinforce durable competitive advantage.
Investor Backing & Capital Strength: Operating as a Roche subsidiary provides access to significant capital, global reach, and integration with a major diagnostics portfolio. Roche’s 2024 reorganization moving the business into Diagnostics and restating sales signals sustained strategic importance and support.
Product Line Growth: The portfolio continues to expand with new and updated assays across tissue and liquid CGP, hereditary germline testing, and MRD offerings. Ongoing FDA/MHLW label additions and collaborations indicate expansion rather than contraction.
